Annual Report

Overview

The report describes Implantica's 2025 progress toward establishing RefluxStop® as a new standard of care, including major FDA PMA milestones and launch preparation. It highlights positive NICE guidance in the UK and real-world safety evidence from 602 patients across 22 European centers. The report also presents sustainability, innovation, and human capital as contributors to long-term value creation.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services